Flarex®

Fluorometholone 0.1% · ophthalmic suspension

Steroid

• Route restriction: Topical ophthalmic use only; not for injection.
• Prolonged use: May produce glaucoma, optic nerve damage, defects in visual acuity and visual field, and cataract formation, and may aid establishment of secondary ocular infection through suppression of host response.
• Steroid IOP response: In a small study the average time to a pressure rise was significantly longer than with dexamethasone phosphate, but the ultimate magnitude of the rise was equivalent and a small percentage rose significantly within three days; check IOP frequently.
• Herpes simplex infection: Treatment requires great caution.
• Acute purulent infection: May be masked or exacerbated by the presence of steroid.
• Corneal wound healing: May be slowed by topical ophthalmic corticosteroids.
• Corneal or scleral thinning: Perforation has occurred with chronic topical steroid use in diseases that thin these tissues.
• Fungal keratitis: Particularly prone to develop with long-term local steroid application; consider fungal invasion in any persistent corneal ulceration where a steroid has been or is in use.
• Soft contact lenses: Benzalkonium chloride 0.01% may be absorbed; remove lenses to instill and reinsert 15 minutes later.
• Transient blurred vision: Follows dosing; relevant to driving and operating machinery.